Michael Gleeson, SVP, Corporate Accounts at GenMark Diagnostics, Inc. (GNMK), sold 3,895 shares at $19.35 ($75K) on 2021-02-23, disclosed to the SEC on 2021-02-25.
Seasonal sale ($75k) by SVP, Corporate Accounts — this insider has traded GNMK in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.35 | 1,432 | $28K | 37.0% |
| 2 | $19.12 | 2,463 | $47K | 63.0% |
| Total | $19.20 avg | 3,895 | $75K | 100% |
| Filing → |
| GNMK | SELL | 2021-01-25 | $939K | — | Filing → |
| GNMK | SELL | 2020-11-25 | $43K | — | Filing → |
| GNMK | SELL | 2020-11-20 | $23K | — | Filing → |